Investigations in breast cancer cells have revealed that the up-regulation of ING5 leads to a decrease in cell proliferation, reduction in glucose metabolism, induction of cell cycle arrest, reduction in the migratory potential and invasive properties, induction of apoptosis, autophagy, and senescence, and the mesenchymal–epithelial transition (MET). This evidence concerns the gene ING5 and breast cancer.